Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Metabolism of 12(R)-HETE in corneal tissue produces predominantly the compound resulting from the loss of four carbon atoms through β-oxidation from C-1. This metabolite is 8(R)-hydroxy hexadecatrienoic acid (8(R)-HHxTrE) or 2,3,4,5-tetranor 12(R)-HETE.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 μg | 35 days | $ 396.00 | |
50 μg | 35 days | $ 765.00 | |
100 μg | 35 days | $ 1,440.00 |
Description | Metabolism of 12(R)-HETE in corneal tissue produces predominantly the compound resulting from the loss of four carbon atoms through β-oxidation from C-1. This metabolite is 8(R)-hydroxy hexadecatrienoic acid (8(R)-HHxTrE) or 2,3,4,5-tetranor 12(R)-HETE. |
Molecular Weight | 266.381 |
Formula | C16H26O3 |
CAS No. | 135271-51-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMF: 25 mg/mL
0.1 M Na2CO3: 2 mg/mL
DMSO: 25 mg/mL
PBS (pH 7.2): 0.5 mg/mL
Ethanol: 30 mg/mL
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
tetranor-12(R)-HETE 135271-51-1 tetranor-12HETE tetranor 12(R) HETE tetranor12(R)HETE inhibitor inhibit